Ad-hoc | 31 May 2002 08:31
Capital Stage AG
english
Sharp improvement in results expected per 30.6.2002 following a loss in the 1st
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
Sharp improvement in results expected per 30.6.2002 following a loss in the 1st
+++ The business development of Capital Stage AG in the first three months of
the fiscal year was shaped by the continuing poor state of the stock markets. A
consolidated post-tax result of -2.96 million euros (1st quarter of 2001: -2.10
million euros) was achieved on group earnings of 0.97 million euros (31.3.2001:
1.42 million euros). The result before interest, taxes, depreciation and
amortisation (EBITDA) was -2.12 million euros compared with -2.08 million euros
per the same date of the previous year. Adjusted for splitting, the DVFA result
per share was -0.12 euros, following -0.08 euros in the same quarter last year.
The disposal of Universal Prints and Handel Verlag GmbH and of stakes in
farmatic biotech energy ag in the 2nd quarter of 2002 means that a sharp
improvement in first-half results can be expected.
The result for the period at the Investment division was negative, with earnings
of -0.50 million euros and earnings before taxes and interest (EBIT) of -0.95
million euros. Despite the increasing decline in turnovers from trading on stock
markets, the EBIT at the Banking business division was able to be improved
sharply to -1.14 million euros per 31.03.2002 compared with -2.13 million euros
on the same date in the previous year. Its earnings were 1.39 million euros,
following 1.60 million euros in the same period last year. In the Services
division, an EBIT of -0.60 million euros and earnings of 0.08 million euros
were achieved in the 1st quarter.
The number of employees at the group rose year-on-year from 81 to 96 as a result
of the incorporation of Futura Capitalis subsidiaries in the 3rd quarter of
2001. Nevertheless, administrative costs in the group were able to be kept
constant at 3.55 million euros per 31.03.2002 (31.3.2001: 3.55 million euros).
This is due above all to the successful implementation of cost adjustment
measures initiated in the 4th quarter of 2001. These resulted in a fall of
around 20 % in the number of employees at the group in the past quarter. At the
same time, staff at the Banking business division waived part of their salary
for a limited period of time.
As a result of the cost-cutting and restructuring measures and sale of the stake
in farmatic, the company expects to achieve a balanced consolidated result in
fiscal 2002.
end of ad-hoc-announcement (c)DGAP 31.05.2002
Issuer’s information/explanatory remarks concerning this ad-hoc-announcement:
The complete quarterly report is available for downloading as a pdf-file from
http://www.capitalstage.com.
Contact: Louis Günther / Investor Relations, Domstraße 17, Capital Stage AG,
D-20095 Hamburg, phone: +49 (0)40. 37 85 62 622, fax: +49 (0)40. 37 85 62 611,
louis.guenther@capitalstage.com, www.capitalstage.com
——————————————————————————–
WKN: 609500; ISIN: DE0006095003; Index: SDax
Listed: Geregelter Markt in Frankfurt (SMAX) und Hamburg; Freiverkehr in Berlin,
Düsseldorf und Stuttgart
310831 Mai 02